Arizona startup ReSuture (NSF-2223976) is developing a synthetic vascular tissue to improve surgical training, reduce complications, and improve patient care. The company’s models mimic real surgical conditions, providing hands-on training experiences for students and surgeons. Article via ABC15 Arizona